US 11912714
Spiropyrrolidine derived antiviral agents
granted A61PA61P31/14
Quick answer
US patent 11912714 (Spiropyrrolidine derived antiviral agents) held by Enanta Pharmaceuticals, Inc. expires Mon Feb 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Feb 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61P, A61P31/14